Table 4.
Vaccine | Kittens (≤ 16 weeks) | Adult and Adolescent (> 16 weeks) | Comments |
---|---|---|---|
Panleukopenia Virus (FPV) | Administer a single dose at the time of admission as early as 4 to 6 weeks of age; then, every 2‐4 weeks until 16 weeks of age if still in the facility | Administer a single dose at the time of admission; repeat in 2‐4 weeks | MLV preparations are preferable. Use of intranasal FPV vaccines is generally not recommended in the shelter environment. Use of intranasal FCV/FHV‐1 MLV vaccines may be preferable when rapid onset (48 hrs) of immunity is important. Post‐vaccinal sneezing, more commonly seen following administration of intranasal FCV/FHV‐1 vaccine, may be impossible to distinguish from active infection |
Feline Herpesvirus‐1 (FHV‐1) | |||
Feline Calicivirus (FCV) | |||
The earlier recommended age (4 weeks) and short end of the interval (2 weeks) should be used in very high risk environments or during outbreaks | |||
Rabies | If at all, a single dose should be administered at the time of discharge from the facility | If at all, a single dose should be administered at the time of discharge from the facility | The administration of rabies vaccine will be determined by whether the shelter is in a country in which the disease is endemic, and by local statute |
The VGG does not recommend the use of other feline vaccines in the shelter situation